ARCHIVES

Sirolimus-Containing Therapy Reduces GVHD, Study Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

June 30, 2006

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993

Wilex, Fox Chase, Begin Trial Of WX-UK1 Targeting Invasion

May 28, 2004

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

ACS Says Its Goals, Patients’ Coalition, Similar, Supports Bill

March 15, 1996

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

November 7, 1975